PEOPLE - Baxter makes appointment:
This article was originally published in Clinica
The president of US company Baxter, Harry Jansen Kraemer, has been named as its CEO, effective December 31 1998. He will replace Vernon Loucks who will remain as chairman of Baxter's board of directors. William Kilgallon has been promoted to director of global marketing, peritoneal dialysis solutions, for Baxter Healthcare. He was previously director of European marketing of PD solutions.
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.